Horsemen's Benevolent and Protective Associaiton

On Friday--the final day of the National HBPA Conference at Prairie Meadows--a panel entitled "Establishing No-Effect Thresholds and the Importance for the Industry" was led by practicing equine veterinarian and researcher Dr. Clara Fenger. She cited the Horseracing Integrity & Safety Authority's enabling legislation that HISA-covered horses "should compete only when they are free from the influence of medications ..." (her emphasis added). Fenger's point: Testing many substances to limit of detection--if the lab can find it, it's a violation, no matter how tiny the amount and whether it impacts...

The span between Memorial Day and the third leg of the Triple Crown is often a quiet one in the racing world. Not this year, though. Here's a shaking-out of a reporter's notebook from a week that generated some unexpected headlines. Louisiana's move to more lenient medication rules: TDN's survey of seven trainers--Steve Asmussen, Brad Cox, Michael Stidham, Tom Amoss, Al Stall, Dallas Stewart, Cherie DeVaux--spoke volumes about the announcement by the Louisiana Racing Commission that it would be implementing "emergency" standards that softened a number of drug-regulating standards as...